A US Food and Drug Administration perspective on evaluating medical products for Ebola

被引:9
|
作者
Russek-Cohen, Estelle [1 ]
Rubin, Daniel [2 ]
Price, Dionne [2 ]
Sun, Wellington [1 ]
Cox, Edward [2 ]
Borio, Luciana [3 ]
机构
[1] US FDA, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
[2] US FDA, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
[3] US FDA, Off Commissioner, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
关键词
Therapeutic clinical trials; vaccine clinical trials; Ebola; SIERRA-LEONE; VACCINE; TRIALS;
D O I
10.1177/1740774515620613
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
[No abstract available]
引用
收藏
页码:105 / 109
页数:5
相关论文
共 50 条
  • [31] Transparency at the US Food and Drug Administration
    Califf, Robert M.
    JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 24 - 28
  • [32] Life Cycle of Medical Product Rules Issued by the US Food and Drug Administration
    Hwang, Thomas J.
    Avorn, Jerry
    Kesselheim, Aaron S.
    JOURNAL OF HEALTH POLITICS POLICY AND LAW, 2014, 39 (04) : 751 - 780
  • [33] IOM, US Food and Drug Administration to study clearance process for medical devices
    Naditz, Alan
    TELEMEDICINE JOURNAL AND E-HEALTH, 2009, 15 (10): : 916 - 916
  • [34] Concepts in US Food and Drug Administration Regulation of Artificial Intelligence for Medical Imaging
    Kohli, Ajay
    Mahajan, Vidur
    Seals, Kevin
    Kohli, Ajit
    Jha, Saurabh
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 213 (04) : 886 - 888
  • [35] Integrated Drug Reviews at the US Food and Drug Administration
    Woodcock, Janet
    Stein, Peter
    Bugin, Kevin
    JAMA INTERNAL MEDICINE, 2020, 180 (09) : 1248 - 1250
  • [36] TRENDS IN APPROVAL OF ADVANCED THERAPY MEDICINAL PRODUCTS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION
    Alsheikh, M. Y.
    Shukla, V
    Seoane-Vazquez, E.
    VALUE IN HEALTH, 2018, 21 : S261 - S261
  • [37] Adverse Events Reported to the US Food and Drug Administration for Cosmetics and Personal Care Products
    Kwa, Michael
    Welty, Leah J.
    Xu, Shuai
    JAMA INTERNAL MEDICINE, 2017, 177 (08) : 1202 - 1204
  • [38] Working with the US Food and Drug Administration to obtain approval of products under the Animal Rule
    Park, Glen D.
    Mitchel, Jules T.
    COUNTERMEASURES AGAINST CHEMICAL THREATS, 2016, 1374 : 10 - 16
  • [39] Evaluation of a US Food and Drug Administration mandate to limit acetaminophen in prescription combination products
    Goldberger, David
    Vearrier, David
    CLINICAL TOXICOLOGY, 2017, 55 (05) : 420 - 420
  • [40] Analysis of US Food and Drug Administration Warning Letters within dermatological care products
    Gorrepati, P. L.
    Smith, G. P.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (01) : 194 - 196